Back to Top

PAN Foundation and ZERO – The End of Prostate Cancer Announce Partnership to Provide Financial Assistance for Metastatic Castrate Resistant Prostate Cancer Patients

 

Washington, D.C., August 5, 2013 – The Patient Access Network (PAN) Foundation and ZERO – The End of Prostate Cancer have joined forces to provide comprehensive support for patients with metastatic castrate resistant prostate cancer (mCRPC). The partnership will leverage PAN’s existing mCRPC financial assistance program coupled with ZERO’s best in class educational resources for mCRPC patients and caregivers.

“The world of prostate cancer treatment is changing rapidly, and we’re evolving to better serve patients in need,” said Patrick McKercher, PAN Foundation President. “This diagnosis would have been a death sentence just a few years ago, but is now being treated successfully. As life-saving, targeted therapies become available, we want to ensure that patients are able to access their medications without the burdensome out-of-pocket cost sharing obligations for treatment.”

By raising awareness and expanding visibility of PAN and the assistance PAN provides among a broader audience of mCRPC patients, families, providers and patient advocates, the PAN Foundation and ZERO hope to increase donations to PAN’s mCRPC financial assistance program. In doing so, PAN and ZERO hope to be able to provide a reliable source of financial assistance for patients who are struggling to afford their medications because of high out-of-pocket costs.

“Financial assistance is too often mCRPC patients’ only route for initiating or continuing treatments that they’re told are their only hope,” explained Korab Zuka, PAN Foundation Vice President of External Relations and Patient Services. “We want to make sure that these patients not only have a reliable financial assistance resource, but also that they and their families have access to the most up-to-date educational resources available for their diagnosis. This first-of-its-kind partnership encourages a more holistic approach to patient assistance, which we hope will lead to better patient outcomes.”

“There are more than two million prostate cancer patients in the U.S. today and too many of them are cut off from affording treatments they desperately need to fight the disease,” said Jamie Bearse, President & CEO of ZERO – The End of Prostate Cancer. “We are honored to partner with PAN Foundation to stop the pain and suffering due to prostate cancer by providing education and support to patients with advanced disease.”

About ZERO – The End of Prostate Cancer

ZERO - The End of Prostate Cancer is a national nonprofit organization with the mission to end prostate cancer. As a leader in the fight against prostate cancer, ZERO advances research, encourages action, and provides education and support to men and their families. ZERO's premier programs include the ZERO Prostate Cancer Challenge, the largest men's health event series in America. ZERO is a 501c3 charity, a Better Business Bureau member and 89 cents of every dollar donated goes to research and programs. For more information, visit www.zerocancer.org.

About the PAN Foundation

The Patient Access Network (PAN) Foundation is dedicated to providing help and hope to patients who would otherwise be unable to afford high-cost specialty medications. PAN envisions a society in which every individual can access needed medical care, offering hope for a healthy tomorrow. PAN provides assistance through nearly 50 disease-specific programs designed to help patients being treated for certain cancers, chronic illnesses, and rare diseases. Through a streamlined application process and state of the art online tools, the PAN Foundation is able to ensure that patients are put on the fast track to therapy. For more information about the PAN Foundation, please visit www.PANfoundation.org.